Total Payments
$5,468
2024 Payments
$702.99
Companies
38
Transactions
380
Medicare Patients
6,008
Medicare Billing
$798,165
Payment Breakdown by Category
Food & Beverage$5,445 (99.6%)
Education$23.13 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,445 | 375 | 99.6% |
| Education | $23.13 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,384 | 90 | $0 (2024) |
| GlaxoSmithKline, LLC. | $579.28 | 44 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $432.75 | 28 | $0 (2022) |
| PFIZER INC. | $427.79 | 31 | $0 (2024) |
| Novo Nordisk Inc | $384.33 | 27 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $360.04 | 26 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $247.35 | 17 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $219.87 | 20 | $0 (2021) |
| IRONWOOD PHARMACEUTICALS, INC | $198.25 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $143.52 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $702.99 | 43 | ABBVIE INC. ($445.70) |
| 2023 | $751.67 | 38 | ABBVIE INC. ($466.89) |
| 2022 | $602.85 | 36 | ABBVIE INC. ($264.16) |
| 2021 | $714.01 | 58 | Janssen Pharmaceuticals, Inc ($180.76) |
| 2020 | $766.04 | 53 | Janssen Pharmaceuticals, Inc ($151.49) |
| 2019 | $732.10 | 58 | Sunovion Pharmaceuticals Inc. ($204.45) |
| 2018 | $634.05 | 48 | Sunovion Pharmaceuticals Inc. ($98.97) |
| 2017 | $564.09 | 46 | GlaxoSmithKline, LLC. ($144.62) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Obesity | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: GI | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: GI | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.73 | General |
| Category: GI | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Inflammation | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,779 | 2,974 | $556,061 | $227,925 |
| 2022 | 29 | 1,526 | 2,589 | $495,071 | $188,423 |
| 2021 | 24 | 1,273 | 2,162 | $438,760 | $175,238 |
| 2020 | 22 | 1,430 | 2,434 | $538,161 | $206,579 |
Total Patients
6,008
Total Services
10,159
Medicare Billing
$798,165
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 415 | 1,080 | $221,400 | $85,665 | 38.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 85 | 85 | $45,050 | $23,983 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 183 | 183 | $40,626 | $22,509 | 55.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 107 | 182 | $37,128 | $16,531 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 86 | 130 | $36,140 | $14,991 | 41.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 152 | 161 | $33,488 | $13,982 | 41.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 28 | 67 | $35,443 | $10,978 | 31.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 80 | 82 | $32,226 | $10,017 | 31.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 40 | $17,720 | $8,438 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 108 | $15,012 | $5,563 | 37.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 154 | 385 | $13,475 | $3,660 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 46 | $6,486 | $2,643 | 40.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 95 | 95 | $2,280 | $2,234 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $2,068 | $1,273 | 61.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,204 | $998.24 | 31.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 17 | 35 | $2,765 | $995.20 | 36.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 24 | $2,472 | $947.76 | 38.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 93 | $4,464 | $821.60 | 18.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 17 | 17 | $1,105 | $539.24 | 48.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 32 | $1,824 | $451.98 | 24.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $765.00 | $372.30 | 48.7% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 11 | 11 | $605.00 | $232.11 | 38.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 35 | 45 | $315.00 | $99.00 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 296 | 725 | $148,735 | $55,443 | 37.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 145 | 298 | $60,792 | $23,305 | 38.3% |
About Dr. William Martin, MD
Dr. William Martin, MD is a Family Medicine healthcare provider based in North Conway, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215115639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Martin, MD has received a total of $5,468 in payments from pharmaceutical and medical device companies, with $702.99 received in 2024. These payments were reported across 380 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,445).
As a Medicare-enrolled provider, Martin has provided services to 6,008 Medicare beneficiaries, totaling 10,159 services with total Medicare billing of $798,165. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location North Conway, NH
- Active Since 02/07/2008
- Last Updated 08/16/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215115639
Products in Payments
- VRAYLAR (Drug) $953.40
- XARELTO (Drug) $415.85
- TRELEGY ELLIPTA (Drug) $282.86
- LONHALA MAGNAIR (Drug) $236.61
- CHANTIX (Drug) $194.56
- UBRELVY (Drug) $180.31
- Ozempic (Drug) $168.05
- Linzess (Drug) $160.11
- JANUVIA (Drug) $153.01
- ANORO (Drug) $149.97
- ELIQUIS (Drug) $129.62
- LEQVIO (Drug) $126.63
- ENTRESTO (Drug) $120.72
- LINZESS (Drug) $115.24
- FARXIGA (Drug) $113.91
- XIFAXAN (Drug) $104.32
- BREO (Drug) $67.03
- SPIRIVA (Drug) $63.82
- BROVANA (Drug) $59.91
- Otezla (Drug) $59.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in North Conway
James Glazer, Md, MD
Family Medicine — Payments: $48,238
Family Medicine $48,238
Dr. Brian Sponseller, Md, MD
Family Medicine — Payments: $15,816
Family Medicine $15,816
Sohaib Siddiqui, Md, MD
Family Medicine — Payments: $1,776
Family Medicine $1,776
Michael Badger, M.d, M.D
Family Medicine — Payments: $985.05
Family Medicine $985.05
Jennifer Smith, Do, DO
Family Medicine — Payments: $803.90
Family Medicine $803.90
Craig Smith, D.o, D.O
Family Medicine — Payments: $510.40
Family Medicine $510.40